Health score, price, valuation, risk signals, and key metrics at a glance.
Strongest: Balance Sheet & Red Flags (17/25); weakest: Growth (2/25).
Data-driven signals worth keeping an eye on across the last 8 quarters
Operating margins dropped 34.4% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
Revenue has softened, declining in 5 quarters. Watch for further erosion.
as of December 2025
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Shares outstanding increased 90853.9% — significant dilution, likely from stock compensation or capital raises.